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The effectiveness of the antihistamne chiorpheniramine mideate in preventing the early performance decrement In montkeys ftillowing a supralethal djAse of ionizing radiation was investigated. Twenty-five caenivn~eys (Ylacaea mulatta) were tiained to perform a discrete trial, cted avoidance-task. .:Ten of these mon1~eys w~re inijected intravenously with isotonic saline 30 minuites before irraditilon. Five monkeys wer injeced with 20 mg of chiorphnrmn anwere performnance tested 24 hours prior to irradiation. These five animals and 10 addiional animals were then injected with f .. i N~ .10 mg of chlorpheniramine at 60 minutes axid at 30 minutes befciu ifradiation. The monkeys were tested twid their perfornance was recorded for 2 hours following a arkedlv superior to that of the saline -treated group during the first 30 minutes postirradiation (the period generally associated with early1 trnsen inaaa t) it ~the exception of one group %if five monkeys, the antih! staml e -treated animals peformed signifteantly better than the saline-rae 1%ney dui 1 entIre 2-hour post Irradiation observatlon period. Tihe average blood pressure of the chiorpheniranllnetreatd monkeys was higher than tOmt of tho saline-trated monkeys throughout the observation period. These findings showv that chlorphaniramine prevents the performanc decrement and reduces th severity of hypotenglon observed in mionkeys following 
71..
e., ~. An earlier study -showed that the severe decline in blood pressure occurring in monkeys immediately following a supralethal dose (4000 rads) of ionizing radiation can be reduced or prevented by the preirradiation injection of a massive dose of an antihistamine, chiorpheniramine. The present study was designed to test the effectiveness of chlorpheniramine in preventing the performance de-rement g,3nerally
J ~observed in monkeys following such a dose of radiation.
Twenty-five rhesus monkeys were trained to perform a simple cued avoidance Ionizing radiation is known to release histamine, a powerful vasodilator whichi is capable of producin~g many of the more overt effects seen during ETI. An earlier 4 study showed that pretreating monkeys. with a massive dlose of an antihyismino, 1,3 whichi acts by occupying receptor sites on target c011S, prevonted the gros4-altis of incapacitationi and significantly reducud hypotension doring the ETI period; but the mechanisms by wVIioli this drug docreasos E-.TI offocts i re not kown.
The Present S( ey xaniflos the offectivelness of~ chlorphouiramine finp vltng . .the porte imance decreiiint of task trained miikcys following a silglo 4-krad (lose of mixed gai-nia-noutroii radiation. and surgery used in the catheterizat, 'n procedure. Catheters were not placed in the animals of t'is group. These monkeys were injected wih 20 mg (-5. 7 mg/kg) oi chliorpheniramine in a superficial leg vein 60 minutes before irradiation.
All monkeys were given a 100-trial performance test beginning 25 minutes prior . to recelvinr. i midline tissue dose of 4000 + 400 rads of mixed gamma-neutron radiation from the AFRIU-TiUGA reactor. The radiation was delivered as a single pulse of -.
I ~
:. :hr (~s hort duration (-5u msec).
Postirrudiation performance testing began 5 seconds after the pulse. Each test period (block) consisted of 100 trials. The performance testing of all monkeys was continued for 2 hours after irradiation unless death intervened. During this time they were visually monitored via closed-circuit television. Blood pressure was recorded for the monkeys in Groups A, B, and C. The average correct response for each * 2-minute interval (10 trials) was calculated and plotted at the midpoint of that interval.
After each block of 100 trials, there was a 3. 4-minute rest period. Following the initial 2-hour postirradiation testing period, the monkeys of Group D were given a 100-trial test each hour until they died.
The results of this study were evaluated using the following criteria:
Performance decrement. The monkeys were trained to perform at or better than 90 percent correct response. Performance less than 90 percent correct was considered a performance decrement.
Early transient incapacitation (ETI). Failure to respond -for four or more
consecutive trials during the first 30 minutes postirradiation, followed by a resumption of task performance, was considered ETI.
Permanent colnplete incapacitation (C.
A period in which the animal failed to vespond was considered PCI, and terminated In death.
III. RESULTS
The postirradiation performance and mean arterial blood pressure of individual monkeys treated with isotonic saline or chlorpheniramine are shown in Figures 1 through 4. The average postirradiation performance of each treatment group is plotted in Figure 5 and the average blood pressure for each group is presented in Figure 6 .
Performance and latency of response during the 2-hour period following chlorpheniramine administration (24 hours preirradiztion) were not significantly different from the pretrt.atment values of the nonirradlated monkeys (Group C). Approximately 8 minutes postirradiation, LX was unable to operate the lever as vomitus on lever prevented accurate responses although hie was performing corv'eotly. 
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The immediate postirradlation decline in blood pressure in the chlorphemiran etreated monkeys (Figure 6 ) was not as severe as that of the saline-treated monkeys.
However, the. only group means that differed sinfcanyweetoefGrpsAad3 after 20 minutes postirradlation (p <.05, Student's 'It".test). There was no correlation between, the fall of moan arterial blood pro and Sthe occurrenco of severe performance docroment. Some witnals stopped prforming z * (luring the time that their blood pressure measurements were well above critical levels (Figures 1, 2 and 3) . However, no animal with blood pressure below critical levels performed adequately for more than a few minutes.
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The poorer performance of those animals which received chlorpheniramine on 2 consecutive days and were then irradiated may be explained by the fact that although the plasma half-life of chlorpheniramine (in the dog) 6 ' 7 is only 3 hours, and its antihistaminic effects last only 4 to 6 hours, 3 the metabolites of chlorpheniramine have i half-life of approximately 10 days. 7 The performance decrement might be secondary to the toxic effects of metabolites of chlorpheniramine rather than to the histamineantihistamine relationship of chlorpheniramine; however, there is no experimental evidence in support of this latter supposition.
V. CONCLUSIONS
The antihistamine chlorpheniramine maleate is effective in preventing ETI, postirradiation performance decrement, and in reducing the hypotension observed in monkeys after a 4000-rad dose of mixed gamma-neutron radiation. Since the major pharmacological effect of chlorpheniramine is blocking histamine receptor sites, its effectiveness in preventing or modifying the radiation-induced performance changes and hypotension can be taken as further evidence that histamine is involved in the acute radiation syndrome. However, the ETI-ameliorating properties of chlorpheniramine are not mediated through the maintenance of arterial blood pressure. An earlier study 9 in which similarly trained and irradiated monkeys were infused with norepinephrine so that blood pressure was maintained above 100 mm tHg did not differ significantly in performance from controls. Some mechanism other than deficient blood pressure, yet capable of being ameliorated by chlorphenlramine, is implicated in ETI.
